Pharma Middle East

Biography

Dr. Janak Padia is presently working as a Professor in the Center of Biomolecular Therapeutics (To evaluate and prioritize its project portfolio and to accelerate development of innovative drugs) at University of Maryland, United States. He was Vice President, Drug R&D Services at Pharmaron and managed integrated projects for chemistry, lead optimization, preclinical candidate identification and development, and IND enabling studies for clients. He has over 25 years of industrial experience in cutting edge drug discovery and development experience and has held management positions of increasing responsibility. Prior to Pharmaron, he was also Director of Chemistry and Drug Development at Avalon Pharmaceuticals where he oversaw a range of drug discovery and development programs and participated in the strategic management of the company. He has extensive experience in drug discovery and development processes, technology evaluation and implementation of project management tools to drive the projects to completion. He also has excellent knowledge drug development, formulation development, IND enabling studies, GLP Tox evaluations, GMP drug manufacturing and regulatory affairs. Dr. Padia has also worked for Parke-Davis/Warner-Lambert (now Pfizer), Discovery Partners, and the NCGC-NCATS-NIH in the therapeutic areas of Cancer, Cardiovascular, CNS and antiviral therapeutics. He has led drug discovery and development efforts during his career that resulted in the identification of several development candidates in the cancer and CNS area. He has authored several scientific publications and is also the inventor of many patents. He holds an adjunct position at Georgetown University Medical Center and serves as an advisor for Drug Discovery Program at GUMC and NIDDK/NIH.

Research Interest

Drug development, formulation development, IND enabling studies, GLP Tox evaluations, GMP drug manufacturing and regulatory affairs